Howard Sofen - Dissemin

Language
Login

All papers authored by Howard Sofen

This paper was not found in any repository, but could be made available legally by the author.

2021 R. B. Warren

ORCID

ORCID

, H. Sofen

ORCID

ORCID

ORCID

, F. Brock, C. Arendt, F. Fierens, A. Blauvelt

ORCID

Three‐year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

A. S. Van Voorhees

ORCID

, L. Stein Gold, M. Lebwohl, B. Strober

ORCID

, H. Sofen

ORCID

, K. Papp

ORCID

, J. Bagel, Z. Zhang, M. Paris, Y. Wang

Efficacy and safety of apremilast in patients with moderate‐to‐severe plaque psoriasis of the scalp: results up to 32 weeks from a randomized, phase III study

Upload

This paper was not found in any repository, but could be made available legally by the author.

Andrew Blauvelt

ORCID

, Kenneth B. Gordon, Patricia Lee, Jerry Bagel, Howard Sofen

ORCID

, Benjamin Lockshin, Ahmed M. Soliman, Ziqian Geng, Tianyu Zhan

ORCID

, Gabriela Alperovich, Linda Stein Gold

ORCID

Efficacy, safety, usability, and acceptability of risankizumab 150 mg formulation administered by prefilled syringe or by an autoinjector for moderate to severe plaque psoriasis

Upload

This paper was not found in any repository, but could be made available legally by the author.

2019 A. Blauvelt, H. Sofen

ORCID

, K. Papp, M. Gooderham, S. Tyring, Y. Zhao, S. Lowry, A. Mendelsohn, J. Parno, K. Reich

Tildrakizumab efficacy and impact on quality of life up to 52 weeks in patients with moderate‐to‐severe psoriasis: a pooled analysis of two randomized controlled trials

Upload

This paper was not found in any repository, but could be made available legally by the author.

M. Gooderham, B. E. Elewski, D. M. Pariser, H. Sofen

ORCID

, A. M. Mendelsohn, S. J. Rozzo, Q. Li

Incidence of Serious Gastrointestinal Events Among Tildrakizumab‐Treated Patients With Psoriasis

Upload

This paper is made freely available by the publisher.

2017 C. Paul, L. Guenther, H. Torii, H. Sofen

ORCID

, R. Burge, C. Y. Lin, A. Potts Bleakman, L. Mallbris, Y. Poulin

Impact of ixekizumab on facial psoriasis and related quality of life measures in moderate-to-severe psoriasis patients: 12-week results from two phase III trials

Download from onlinelibrary.wiley.com

This paper is made freely available by the publisher.

A. Blauvelt, K. Reich, S. Mehlis, F. Vanaclocha, H. Sofen

ORCID

, W. Abramovits, Y. Zhao, I. Gilloteau, E. Davenport, N. Williams, A. Guana, S. Tyring

Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate-to-severe plaque psoriasis: 52-week results from the CLEAR study

Download from doi.org

Missing publications? Search for publications with a matching author name.